Basit öğe kaydını göster

dc.contributor.authorTaviloglu, Korhan
dc.contributor.authorYanar, Hakan
dc.date.accessioned2021-03-03T11:45:20Z
dc.date.available2021-03-03T11:45:20Z
dc.date.issued2007
dc.identifier.citationTaviloglu K., Yanar H., "Fat embolism syndrome", SURGERY TODAY, cilt.37, sa.1, ss.5-8, 2007
dc.identifier.issn0941-1291
dc.identifier.otherav_29c4c5e3-17d5-4eee-93a9-b088c13fca58
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/32891
dc.identifier.urihttps://doi.org/10.1007/s00595-006-3307-5
dc.description.abstractFat embolism syndrome (FES) was first described in 1862, but its frequency today is still unclear. A diagnosis of FES is often missed because of a subclinical illness or coexisting confusing injuries or disease. Fat embolism syndrome develops most commonly after orthopedic injuries, but it has also been reported after other forms of trauma such as severe burns, liver injury, closed-chest cardiac massage, bone marrow transplantation, and liposuction. Although FES usually presents as a multisystem disorder, the most seriously affected organs are the lung, brain, cardiovascular system, and skin. Fat embolism syndrome is a self-limiting disease and treatment should be mainly supportive. Many drugs have been used to treat FES, but the results are inconclusive.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectCERRAHİ
dc.subjectKlinik Tıp
dc.subjectTıp
dc.subjectCerrahi Tıp Bilimleri
dc.titleFat embolism syndrome
dc.typeMakale
dc.relation.journalSURGERY TODAY
dc.contributor.department, ,
dc.identifier.volume37
dc.identifier.issue1
dc.identifier.startpage5
dc.identifier.endpage8
dc.contributor.firstauthorID180735


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster